Cargando…

Expression of MUS81 Mediates the Sensitivity of Castration-Resistant Prostate Cancer to Olaparib

This project attempts to clarify the expression of MUS81 in castration-resistant prostate cancer (CRPC) and the effect on drug sensitivity to Olaparib. We collected clinical surgical samples of patients who were suffering from benign prostatic hyperplasia (BPH), common prostate cancer (PCa), and cas...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gong, Lifeng, Tang, Yu, Jiang, Li, Tang, Wei, Luo, Shengjun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9334051/ https://www.ncbi.nlm.nih.gov/pubmed/35910852 http://dx.doi.org/10.1155/2022/4065580

Ejemplares similares

Phosphorylation status of MUS81 is a modifier of Olaparib sensitivity in BRCA2-deficient cells
por: Blandino, Francesca, et al.
Publicado: (2023)

Olaparib vs Cabazitaxel in Metastatic Castration-Resistant Prostate Cancer
por: Wallis, Christopher J. D., et al.
Publicado: (2021)

A winged helix domain in human MUS81 binds DNA and modulates the endonuclease activity of MUS81 complexes
por: Fadden, Andrew J., et al.
Publicado: (2013)

Telomere recombination requires the MUS81 endonuclease
por: Zeng, Sicong, et al.
Publicado: (2009)

Cost-Effectiveness of Genomic Test-Directed Olaparib for Metastatic Castration-Resistant Prostate Cancer
por: Su, Dan, et al.
Publicado: (2021)

Contextualizing Olaparib and Abiraterone in the Current Treatment Landscape for Metastatic Castration-resistant Prostate Cancer
por: Fallara, Giuseppe, et al.
Publicado: (2023)

Olaparib-Induced Purpuric Drug Eruption in a Patient with Castration-Resistant Prostate Cancer
por: Sekine, Mana, et al.
Publicado: (2023)

Human MUS81: A Fence-Sitter in Cancer
por: Chen, Sisi, et al.
Publicado: (2021)

Role of Olaparib in the Management of Metastatic Castration-Resistant Prostate Cancer: A Japanese Clinician’s Perspective
por: Matsumoto, Takashi, et al.
Publicado: (2022)

IKKε Inhibitor Amlexanox Promotes Olaparib Sensitivity through the C/EBP-β-Mediated Transcription of Rad51 in Castrate-Resistant Prostate Cancer
por: Gilbert, Sophie, et al.
Publicado: (2022)

MUS81-EME2 Promotes Replication Fork Restart
por: Pepe, Alessandra, et al.
Publicado: (2014)

Role of PCNA and RFC in promoting Mus81-complex activity
por: Sisakova, Alexandra, et al.
Publicado: (2017)

Marine derivatives prevent wMUS81 in silico studies
por: Ngo, Son Tung, et al.
Publicado: (2021)

Srs2 promotes Mus81–Mms4-mediated resolution of recombination intermediates
por: Chavdarova, Melita, et al.
Publicado: (2015)

Comparative efficacy of olaparib in combination with or without novel antiandrogens for treating metastatic castration-resistant prostate cancer
por: Chen, Xiangyu, et al.
Publicado: (2023)

Clinical Utility of Olaparib in the Treatment of Metastatic Castration-Resistant Prostate Cancer: A Review of Current Evidence and Patient Selection
por: LeVee, Alexis, et al.
Publicado: (2021)

Inhibition of Mus81 by siRNA enhances sensitivity to 5-FU in breast carcinoma cell lines
por: Qian, Ying, et al.
Publicado: (2014)

Mus81-mediated DNA cleavage resolves replication forks stalled by topoisomerase I–DNA complexes
por: Regairaz, Marie, et al.
Publicado: (2011)

The Role of AtMUS81 in Interference-Insensitive Crossovers in A. thaliana
por: Berchowitz, Luke E, et al.
Publicado: (2007)

Substrate specificity of the MUS81-EME2 structure selective endonuclease
por: Pepe, Alessandra, et al.
Publicado: (2014)

Cost-effectiveness of olaparib, a PARP inhibitor, for patients with metastatic castration-resistant prostate cancer in China and United States
por: Xu, Chenxia, et al.
Publicado: (2022)

Response to olaparib in metastatic castration-resistant prostate cancer with germline BRCA2 mutation: a case report
por: Ma, Yi, et al.
Publicado: (2018)

Regulation of circGOLPH3 and its binding protein CBX7 on the proliferation and apoptosis of prostate cancer cells
por: Gong, Lifeng, et al.
Publicado: (2020)

Activity of durvalumab plus olaparib in metastatic castration-resistant prostate cancer in men with and without DNA damage repair mutations
por: Karzai, Fatima, et al.
Publicado: (2018)

Genetic and functional interactions between Mus81–Mms4 and Rad27
por: Kang, Min-Jung, et al.
Publicado: (2010)

Fanconi anemia signaling and Mus81 cooperate to safeguard development and crosslink repair
por: Larin, Meghan, et al.
Publicado: (2014)

MUS81 Inhibition Increases the Sensitivity to Therapy Effect in Epithelial Ovarian Cancer via Regulating CyclinB Pathway
por: Zhong, Ailing, et al.
Publicado: (2019)

The structure-selective endonucleases GEN1 and MUS81 mediate complementary functions in safeguarding the genome of proliferating B lymphocytes
por: Fernandez, Keith Conrad, et al.
Publicado: (2022)

Clinical Utility of Olaparib in the Treatment of Metastatic Castration-Resistant Prostate Cancer: A Review of Current Evidence and Patient Selection [Corrigendum]
Publicado: (2021)

Olaparib outcomes in metastatic castration-resistant prostate cancer: First real-world experience in safety and efficacy from the Chinese mainland
por: Pan, Jian, et al.
Publicado: (2022)

Randomized Trial of Olaparib With or Without Cediranib for Metastatic Castration-Resistant Prostate Cancer: The Results From National Cancer Institute 9984
por: Kim, Joseph W., et al.
Publicado: (2023)

Addition of Olaparib to the New Hormonal Agent Regimen for Metastatic Castration-Resistant Prostate Cancer: A Systematic Review and Meta-Analysis
por: Warli, Syah Mirsya, et al.
Publicado: (2023)

Cooperativity of Mus81·Mms4 with Rad54 in the Resolution of Recombination and Replication Intermediates
por: Matulova, Petra, et al.
Publicado: (2009)

Survival of the Replication Checkpoint Deficient Cells Requires MUS81-RAD52 Function
por: Murfuni, Ivana, et al.
Publicado: (2013)

A protocol to determine the activities of human MUS81-EME1&2 endonucleases
por: Fang, Qianqian, et al.
Publicado: (2022)

Efficacy and safety of olaparib combined with abiraterone in patients with metastatic castration-resistant prostate cancer: a systematic review and meta-analysis of randomized controlled trials
por: Luo, Zhanyang, et al.
Publicado: (2023)

Damage-dependent regulation of MUS81-EME1 by Fanconi anemia complementation group A protein
por: Benitez, Anaid, et al.
Publicado: (2014)

Saccharomyces cerevisiae Mus81-Mms4 is a catalytic, DNA structure-selective endonuclease
por: Ehmsen, Kirk Tevebaugh, et al.
Publicado: (2008)

Novel insights into maintaining genomic integrity: Wee1 regulating Mus81/Eme1
por: Martín, Yusé, et al.
Publicado: (2011)

Cell cycle-dependent regulation of the nuclease activity of Mus81–Eme1/Mms4
por: Gallo-Fernández, María, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_aaiaa94hgthpldsh29u4jnsjnm